Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials

INTRODUCTION: Anemia frequently occurs in chronic kidney disease (CKD), is associated with poor quality of life and cardiovascular outcomes, and its treatment represents a considerable economic burden to the healthcare system. Although effective, the current standard of care for the treatment of ane...

Descripción completa

Detalles Bibliográficos
Autores principales: Agarwal, Rajiv, Anand, Sanjeev, Eckardt, Kai-Uwe, Luo, Wenli, Parfrey, Patrick S., Sarnak, Mark J., Solinsky, Christine M., Vargo, Dennis L., Winkelmayer, Wolfgang C., Chertow, Glenn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2023
Materias:
Patient-Oriented, Translational Research: Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909618/
https://www.ncbi.nlm.nih.gov/pubmed/36450264
http://dx.doi.org/10.1159/000528443

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909618/
https://www.ncbi.nlm.nih.gov/pubmed/36450264
http://dx.doi.org/10.1159/000528443

Ejemplares similares